Achieve Life Sciences ACHV
NASDAQ ACHV
$6.78 +0.06 (+0.89%)
At close: Nov 9, 2026 · 4:00 PM EST

Achieve Life Sciences (ACHV) Asset Writedowns and Impairment (2016)

Updated

Achieve Life Sciences' Asset Writedowns and Impairment was $202,000 in Q4 2016.

Analysis

Achieve Life Sciences (ACHV) Asset Writedowns and Impairment (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Achieve Life Sciences 746.03 Mn 544.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 202,000.00
API Access

Achieve Life Sciences Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ACHV&period=max&api_key=YOUR_API_KEY